ALC-159 Trademark

Trademark Overview


On Tuesday, March 19, 2024, a trademark application was filed for ALC-159 with the United States Patent and Trademark Office. The USPTO has given the ALC-159 trademark a serial number of 98456480. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, March 25, 2025. This trademark is owned by Acuitas Therapeutics, Inc.. The ALC-159 trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

Pharmaceutical preparations, namely, drug delivery agents in the nature of lipid nanoparticle carriers that facilitate delivery of pharmaceutical preparations and nucleic acid therapeutics as pharmaceutical preparations; pharmaceutical preparations comprised of lipid nanoparticles for treating and preventing a wide variety of diseases and disorders

Lipids for scientific purposes, research and development purposes, and research laboratory use in biotechnological product development; lipid nanoparticles for scientific purposes, research and development purposes, and research laboratory use in biotechnological product development; lipid formulations for scientific purposes, research and development purposes, and research laboratory use in biotechnological product development; compositions comprised of lipids and nucleic acids for scientific purposes, research and development purposes, and research laboratory use in biotechnological product development
alc-159

General Information


Serial Number98456480
Word MarkALC-159
Filing DateTuesday, March 19, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, March 25, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 25, 2025

Trademark Statements


Pseudo MarkALC ONE FIFTY NINE
Pseudo MarkALC ONE HUNDRED FIFTY NINE
Goods and ServicesPharmaceutical preparations, namely, drug delivery agents in the nature of lipid nanoparticle carriers that facilitate delivery of pharmaceutical preparations and nucleic acid therapeutics as pharmaceutical preparations; pharmaceutical preparations comprised of lipid nanoparticles for treating and preventing a wide variety of diseases and disorders
Pseudo MarkALC ONE FIVE NINE
Goods and ServicesLipids for scientific purposes, research and development purposes, and research laboratory use in biotechnological product development; lipid nanoparticles for scientific purposes, research and development purposes, and research laboratory use in biotechnological product development; lipid formulations for scientific purposes, research and development purposes, and research laboratory use in biotechnological product development; compositions comprised of lipids and nucleic acids for scientific purposes, research and development purposes, and research laboratory use in biotechnological product development

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateTuesday, March 19, 2024
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 19, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAcuitas Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressVancouver, B.C. V6T1Z3
CA

Party NameAcuitas Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressVancouver, B.C. V6T1Z3
CA

Trademark Events


Event DateEvent Description
Tuesday, March 19, 2024NEW APPLICATION ENTERED
Thursday, September 26, 2024NON-FINAL ACTION WRITTEN
Tuesday, August 13, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 26, 2024NON-FINAL ACTION E-MAILED
Thursday, September 26, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, October 18, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, September 26, 2024ASSIGNED TO EXAMINER
Friday, October 18, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, October 18, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, October 18, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, December 4, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, December 4, 2024ASSIGNED TO LIE
Tuesday, December 17, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 17, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 17, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, December 17, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, October 18, 2024TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Tuesday, December 17, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, December 24, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Tuesday, December 24, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Tuesday, March 4, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 5, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 4, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 4, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 19, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 25, 2025PUBLISHED FOR OPPOSITION
Tuesday, March 25, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, March 5, 2025LAW OFFICE PUBLICATION REVIEW COMPLETED